Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Reed

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Breast Cancer Research and Treatment|October 5, 2007
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancerPaul A Foster, Surinder K Chander, Michael F C Parsons, et al.
Organic & Biomolecular Chemistry|October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modellingFabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Biochemistry|May 4, 2005
First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitorsMatthew D Lloyd, Nethaji Thiyagarajan, Yaik T Ho, et al.
Bioorganic & Medicinal Chemistry|March 11, 2008
Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for designGillian M Allan, Nigel Vicker, Harshani R Lawrence, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Cancer Research|January 7, 2006
The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cellsSimon P Newman, Christopher R Ireson, Helena J Tutill, et al.
Endocrine-Related Cancer|November 8, 2012
STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer modelJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Journal of Medicinal Chemistry|December 22, 2006
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activityMathew P Leese, Bertrand Leblond, Andrew Smith, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Breast Cancer Research and Treatment|October 5, 2007
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancerPaul A Foster, Surinder K Chander, Michael F C Parsons, et al.
Organic & Biomolecular Chemistry|October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modellingFabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Biochemistry|May 4, 2005
First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitorsMatthew D Lloyd, Nethaji Thiyagarajan, Yaik T Ho, et al.
Bioorganic & Medicinal Chemistry|March 11, 2008
Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for designGillian M Allan, Nigel Vicker, Harshani R Lawrence, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Cancer Research|January 7, 2006
The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cellsSimon P Newman, Christopher R Ireson, Helena J Tutill, et al.
Endocrine-Related Cancer|November 8, 2012
STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer modelJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Journal of Medicinal Chemistry|December 22, 2006
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activityMathew P Leese, Bertrand Leblond, Andrew Smith, et al.
Pageof 8